US Obesity Rates: A Potential Turning Point
Recent data suggests a potential decline in US obesity rates for the first time in over a decade.
Recent data suggests a potential decline in US obesity rates for the first time in over a decade.
Over 200 deaths linked to weight-loss injections raise safety concerns in the UK.
Emerging evidence suggests GLP-1 medications may cause hair loss and other side effects.
Patients face unprecedented drug shortages, impacting their health and daily routines.
New research suggests GLP-1 weight-loss drugs may lower breast cancer risk by 30%.